Cyclooxygenase-2-derived endogenous prostacyclin enhances mouse embryo hatching

Jaou-Chen Huang1,4, W.-S.Alfred Wun2, Jennifer S. Goldsby1, Nena Matijevic-Aleksic3 and Kenneth K. Wu3

1 Department of Obstetrics and Gynecology, 3 Vascular Biology Center, Institute of Molecular Medicine and Division of Hematology, Department of Internal Medicine, University of Texas Health Science Center-Houston and 2 Obstetrical and Gynecological Associates, Houston, TX, USA

4 To whom correspondence should be addressed at: Department of Obstetrics and Gynecology, University of Texas Health Science Center-Houston, 6431 Fannin Street, MSB 3.604, Houston, TX 77030, USA. Email: jaou-chen.huang{at}uth.tmc.edu


    Abstract
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
INTRODUCTION: The role of prostaglandins (PGs) in embryo hatching remains controversial. In addition, there is no direct evidence that mouse embryos synthesize PGs. METHODS: The effects of endogenous PG on mouse embryo hatching were evaluated by blocking endogenous PG synthesis with indomethacin. Specific cyclooxygenase (COX) inhibitors were used to identify the role of COX-1- and COX-2-derived PGs. An eicosanoid profile was generated by incubating blastocysts with [3H]arachidonic acid and analysing the metabolites by high performance liquid chromatography. The expression and the localization of COX-1, COX-2 and prostacyclin synthase (PGIS) were examined by western blot analysis and immunohistochemistry. RESULTS: The hatching of embryos cultured in 30 µl of protein-free medium was blocked by indomethacin (P=0.007) or a selective COX-2 inhibitor (P=0.004). Adding back iloprost, a prostacyclin analogue, abolished the effects of the COX-2 inhibitor. Prostacyclin was the most abundant PG produced by mouse blastocysts, which expressed COX-1, COX-2 and PGIS. COX-1, COX-2 and PGIS were expressed in 4-cell stage embryos and beyond; they were present in the inner cell mass and the trophectoderm of the blastocysts. CONCLUSION: Mouse embryos express COX-1, COX-2 and PGIS which catalyse the formation of PGI2; COX-2-derived PGI2 plays a critical role in embryo hatching.

Key words: embryo survival/embryotrophic factor/IVF/non-steroidal anti-inflammatory drugs/preimplantation embryo development


    Introduction
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
A receptive endometrium is indispensable to a successful implantation. The critical role of endometrium-derived prostaglandins (PGs) in implantation is underscored by the failure of embryo reception in cyclooxygenase-2 (COX-2) gene knockout mice and its partial restoration by exogenous prostacyclin (PGI2) (Lim et al., 1999Go). Complete hatching of embryos is a pre-requisite for successful implantation (Hartshorne and Edwards, 1991Go). The role of embryo-derived, endogenous PGs and embryo hatching remains controversial. Earlier studies showed that 10 µmol/l of indomethacin, one of the non-selective COX-1 and COX-2 inhibitors, blocked mouse embryo hatching in vitro (Biggers et al., 1978Go; Hurst and MacFarlane, 1981Go). More recent studies suggested that a much higher concentration of indomethacin (~100 µmol/l) was required to inhibit the hatching of cultured mouse embryos (Chida et al., 1986Go; van der Weiden et al., 1993Go).

Blastocysts from farm animals such as cattle and sheep produce PGs; blastocysts from rabbits also produce PGs (reviewed by Lewis et al., 1989Go). Although PG production by mouse embryos was suggested by some studies, the direct evidence is lacking. Mouse embryos express COX mRNA (Takami et al., 1994Go) and display immunoreactive COX (van der Weiden et al., 1996Go). In addition, PGE2 was detected immunohistochemically in mouse embryos (Niimura and Ishida, 1987Go). The exact eicosanoid profile, especially PGI2 production by mouse embryos, has not been reported. Furthermore, the role of embryo-derived eicosanoids in embryo hatching is unclear.

In this study, we determined eicosanoid production by mouse embryos and evaluated the role of PGI2 in embryo hatching. Our results confirmed earlier reports that 10 µmol/l of indomethacin inhibited mouse embryo hatching. Furthermore, using selective COX-1 and COX-2 inhibitors, we discovered that embryo hatching was suppressed selectively by COX-2 inhibitor and that adding back a PGI2 analogue abolished the effects of the COX-2 inhibitor. Analysis of eicosanoids by reverse phase high performance liquid chromatography (HPLC) revealed that mouse embryos synthesized predominantly PGI2 from exogenous arachidonic acid (AA). Western blot analysis showed that COX-1, COX-2 and PGI2 synthase (PGIS) proteins were expressed by mouse blastocysts. We concluded that COX-2-derived PGI2 enhanced embryo hatching.


    Materials and methods
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Unless stated otherwise, reagents were purchased from Sigma Co. (St Louis, MO).

Harvest and culture of mouse embryos
The care and the manipulation of mice were consistent with the Guide for the Care and Use of Laboratory Animals published by the US National Institute for Health (NIH publication No. 85-23, revised 1996). The research protocol was approved by the Animal Welfare Committee of the University of Texas Health Science Center-Houston.

Mouse embryos were harvested and cultured as described previously (Huang et al., 2003Go) with some modifications. Three-week-old C57Bl/6 female mice were purchased from Harlan (Indianapolis, IN) and 8-week-old C3H male mice were purchased from The Jackson Laboratory (Bar Harbor, ME). Superovulation in the female mice was achieved by i.p. injection of pregnant mare's serum gonadotrophin (5 IU), followed by HCG (5 IU) 46 h later. After receiving HCG, each female mouse was paired with one fertile male mouse. Forty-eight hours later, 2-cell embryos were harvested from the oviducts into {alpha}-minimum essential medium (MEM) supplemented with 25 mmol/l HEPES and 1% bovine serum albumin (BSA) (Irvine Scientific, Santa Ana, CA).

Embryos (17–20 per group) were cultured at 37°C under 5% CO2 in 3 cm plates containing 30 µl droplets of protein-free medium under oil (see next paragraph). Human tubal fluid medium (Sage Biopharma, Bedminster, NJ) was used during the first 48 h and {alpha}-MEM, with Earle's salts and 2 mmol/l glutamine, was used during the second 48 h. After 96 h culture, each embryo was examined for the presence of the zona pellucida. Embryos completely free of the zona pellucida were counted as having completely hatched. The rate of complete hatching was determined by dividing the number of completely hatched embryos by the total number of embryos. Complete embryo hatching was chosen as the end-point because it correlates with the establishment of a viable pregnancy (GoHuang et al., 2004).

Using 30 µl of culture medium per 17–20 embryos was designed to reveal the autocrine/paracrine effects of embryo-derived factors. A similar approach was used previously to show the autocrine effects of embryo-derived transforming growth factor-{beta} (Brison and Schultz, 1997Go) and platelet-activating factor (Lu et al., 2004Go). We confirmed in our preliminary studies that embryos cultured in 30 µl of protein-free medium were optimal for our experiments as they had a significantly higher rate of complete hatching (48%) compared with those cultured in 600 µl of medium with or without protein supplement (30 and 27%, respectively).

Western blot analysis
Monoclonal antibody for COX-1, affinity-purified polyclonal peptide antibody for COX-2 (both from Cayman Chemical, Ann Arbor, MI) and affinity-purified polyclonal peptide antibody for PGIS (a gift from Dr Ke-He Ruan, The University of Texas Health Science Center) were used to detect the respective protein in the total cell lysate of mouse blastocysts. Details of the western blot analysis are described in the accompanying manuscript.

The total cell lysate of blastocysts was prepared as follows. Mouse blastocysts in 2 µl of medium were transferred to 1.5 ml Eppendorf tubes containing 30 µl of lysis buffer (150 mmol/l NaCl, 1% NP-40, 0.25% sodium deoxycholate, 1 mmol/l sodium orthovanadate, 1 mmol/l EGTA and 1 mmol/l sodium fluoride) and protease inhibitors [1 mmol/l 4-(2-aminoethyl) benzene sulphonyl fluoride hydrochloride, 0.8 µmol/l aprotinin, 50 µmol/l betastatin, 15 µmol/l E-64, 20 µmol/l leupeptin hemisulphate, 10 µmol/l pepstatin A, Calbiochem-Novabiochem Corp., San Diego, CA]. The mixture was vortexed for 5 s, centrifuged for 10 s and stirred on ice for 30 min. After two bursts of sonication (Sonifier 250, Branson Co. Danbury, CT), of 1 s each, the protein loading buffer (4x) was added. Afterwards, the supernatant was used for western blot analysis. Lysates from 26, 75 and 67 mouse blastocysts were used for COX-1, COX-2 and PGIS detection, respectively.

Eicosanoid profile
The metabolites of [3H]AA generated by mouse embryos were analysed by a reverse phase HPLC based on a procedure described previously (Sanduja et al., 1991Go). Briefly, 200 mouse blastocysts were incubated in 100 µl of {alpha}-MEM containing 20 µmol/l [3H]AA (150–240 Ci/mmol, ICN Biochemicals, Inc., Irvine, CA) in a 37°C water bath for 30 min. After extraction, the eicosanoids were separated and identified using HPLC as described in the accompanying manuscript. To confirm the identity of a peak, an equal amount of the standard was co-injected with the sample and a doubling in the height of the peak was observed.

Immunohistochemistry and fluorescence microscopy
Affinity-purified COX-1 and COX-2 polyclonal antibodies conjugated with rhodamine (Santa Cruz Biotechnology Inc., Santa Cruz, CA) were used to localize COX-1 and COX-2 in the mouse embryos. The affinity-purified polyclonal PGIS antibody (used in the western blot analysis) and a goat anti-rabbit immunoglobulin G (IgG) antibody coupled with Alexa 488 (Molecular Probes, Eugene, OR) were used to detect PGIS in the mouse embryos. The embryos were first fixed in 4% paraformaldehyde (pH7.4) at 4°C for 30 min. After three washes in phosphate-buffered saline (PBS), the embryos were blocked in Tris-buffered saline (pH7.4) containing 0.05% Tween-20, 5% powder milk and 0.1% Triton X-100 for 20 min at room temperature. The embryos were incubated at 37°C with the respective antibody in blocking buffer for 2 h. In the case of PGIS, there was an additional incubation with goat anti-rabbit IgG coupled with Alexa 488 (0.625 µg/ml) for 30 min at 37°C. Finally, the embryos were mounted in 0.1 mol/l Tris–HCl (pH8.5) containing 16.6% Elvanol 50-42 (DuPont Wilmington, DE) and 2.5% 1,4-diazabicyclo-(2.2.2)-octane. An equal concentration of non-immune rabbit IgG conjugated with fluorescein isothiocyanate (Santa Cruz Biotechnology) in place of conjugated COX-1 and COX-2 antibody was used as negative controls for COX-1 and COX-2, respectively; an equal concentration of pre-absorbed PGIS antibody was used as negative control for PGIS.

Fluorescence microscopy was performed using a Zeiss AxioPlan 2 microscope (Carl Zeiss, Baden-Wuerttemberg, Germany) equipped with appropriate filters. Images were captured using a CCD camera and processed by the AxioVision program (Version 3.0.6).

Statistical analysis
Student's t-test or one-way analysis of variance followed by the indicated post hoc tests was used. P<0.05 was considered statistically significant. The analysis was performed using the InStat® software (GraphPad Prism Software Inc., San Diego, CA).


    Results
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Indomethacin and a selective COX-2 inhibitor blocked embryo hatching
To evaluate the effects of indomethacin on embryo hatching, we cultured embryos (17–20 embryos per group) in 30 µl of protein-free medium for 96 h. Indomethacin significantly reduced the percentage of completely hatched embryos (Figure 1), consistent with an important role for COX metabolites in embryo hatching. Since indomethacin non-selectively inhibits COX-1 and COX-2 activities, we next investigated the influence of selective COX-1 and COX-2 inhibitors on embryo hatching. SC-58125, a selective COX-2 inhibitor, blocked embryo hatching to an extent comparable with indomethacin, whereas SC-560, a selective COX-1 inhibitor, had no effect (Figure 2). Taken together, these results suggest that COX-2-derived prostanoids are involved in embryo hatching.



View larger version (8K):
[in this window]
[in a new window]
 
Figure 1. Indomethacin blocked complete embryo hatching. Two-cell embryos (17–20 per group) were cultured in 30 µl of protein-free medium with or without indomethacin (10 µmol/l). After 96 h, the rate of complete hatching was determined. Indomethacin reduced the rate of complete hatching. The data represent the mean±SD of 13 and three independent observations on control embryos and embryos receiving indomethacin, respectively (*P=0.007).

 


View larger version (11K):
[in this window]
[in a new window]
 
Figure 2. Selective cyclooxygenase (COX)-2 inhibitor blocked complete embryo hatching. Two-cell embryos (17–20 per group) were cultured for 96 h in 30 µl of protein-free medium with 1 µmol/l of specific COX-1 (SC 560) or COX-2 (SC 58125) inhibitors. SC 58125 significantly reduced the rate of complete hatching. The data represent the mean±SD of compete hatching of 11, four and six independent observations on control embryos and embryos receiving SC 560 and SC 58125, respectively (P=0.004, one-way ANOVA; *P<0.01 based on Dunnett's test).

 
Iloprost but not PGE2 or PGF2{alpha} analogue restored embryo hatching
To identify the prostanoid involved in embryo hatching, we added back iloprost (a stable analogue of PGI2), PGE2 and fluprostenol (a stable analogue of PGF2{alpha}) to embryos cultured with selective COX-2 inhibitor (SC 58125) in 30 µl of protein-free medium. The results show that the inhibition of hatching by SC 58125 was reversed by iloprost but not by PGE2 or fluprostenol. Interestingly, embryos receiving iloprost add-back appeared to have a higher percentage of completely hatched embryos than those embryos without the inhibitor treatment (Figure 3).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 3. Iloprost, a prostacyclin (PGI2) analogue, restored the enhanced hatching abolished by COX-2 inhibitor. Two-cell embryos (17–20 per group) were cultured in 30 µl of protein-free medium with selective COX-2 inhibitor (SC 58125) or prostaglandin (or its analogue) where indicated. The rates of complete hatching were determined 96 h later. Compared with embryos cultured with the inhibitor, those cultured without the inhibitor or receiving iloprost add-back had significantly higher rates of complete hatching. The data represent the mean±SD of complete hatching (%) based on eight observations on embryos with the inhibitor, 13 observations on embryos cultured without the inhibitor, five observations on embryos with iloprost add-back and three each observations on PGE2 and fluprotenol add-back (P=0.0013, one-way ANOVA; *P<0.01).

 
Mouse blastocysts produced PGI2 and expressed COX-1, COX-2 and PGIS
Since the exogenously added iloprost restored the hatching blocked by SC 58125, we wondered whether embryos synthesized PGI2. We analysed eicosanoids by reversed phase HPLC. Blastocysts were incubated in {alpha}-MEM containing [3H]AA for 30 min, the medium was collected and eicosanoids in the medium were extracted and analysed by HPLC. 6-Keto-PGF1{alpha}, a stable metabolite of PGI2, was the major product, whereas PGE2 and PGF2{alpha} were detected in relatively small quantities (Figure 4). To confirm that mouse blastocysts possess the enzymatic machinery to synthesize PGI2, we homogenized blastocysts and determined COX-1, COX-2 and PGIS proteins in the cell lysate by western blot analysis. COX-1, COX-2 and PGIS proteins were detected (Figure 5).



View larger version (12K):
[in this window]
[in a new window]
 
Figure 4. Mouse embryos produced abundant PGI2. Two hundred blastocysts were incubated with [3H]arachidonic acid. The medium was collected, eicosanoids extracted and analysed by HPLC. (I denotes 6 keto PGF1{alpha}, the stable metabolite of PGI2; E, PGE2; F, PGF2{alpha}; HHT, heptadecatrienoic acid; HETE, hydroxyeicosatetraenoic acid; AA, arachidonic acid.)

 


View larger version (32K):
[in this window]
[in a new window]
 
Figure 5. Mouse embryos expressed both COX isoforms and prostacyclin synthase (PGIS). Total cell lysates of mouse blastocysts were subject to western blot analysis to detect COX-1, COX-2 and PGIS. The respective affinity-purified antibodies were used for the detection and an enhanced chemifluorescence was used for visualization. Purified COX-1 from sheep seminal vesicles, recombinant human COX-2 and recombinant human PGIS were used as positive controls. Lanes 1, 3 and 5 are positive controls; lanes 2, 4 and 6 are the cell lysates of mouse embryos probed with the respective antibody.

 
Developmental stage-specific expression of COX-1, COX-2 and PGIS in mouse embryos
The developmental stage-specific expression of COX-1, COX-2 and PGIS and their localization in the mouse embryos were examined by immunohistochemistry. Direct immunohistochemistry was used for the detection and the localization of COX-1 and COX-2; indirect immunohistochemistry was used for the detection and the localization of PGIS. Our results show that COX-1 became detectable in 8-cell and later stage embryos and that COX-2 and PGIS became detectable in 4-cell and later stage embryos (Figure 6). Cellular localization analysis shows that all three enzymes were expressed in the trophectoderm and the inner cell mass of the blastocysts.



View larger version (92K):
[in this window]
[in a new window]
 
Figure 6. COX-1, COX-2 and PGIS were expressed in mouse blastocysts. The expression of COX-1, COX-2 and PGIS was studied in all stages of embryos and unfertilized eggs. The localization of COX-1 and COX-2 was accomplished by direct immunostaining using affinity-purified COX-1 and COX-2 antibody conjugated with rhodamine; the localization of PGIS was accomplished via indirect immunostaining using affinity-purified rabbit polyclonal anti-PGIS peptide antibody and donkey anti-rabbit immunoglobulin G (IgG) conjugated with Alexa 488. Pre-absorbed PGIS antibody or fluorescein isothiocyanate-conjugated non-immune IgG (in the case of COX-1 and COX-2) were used as negative controls. COX-1 became detectable in 8-cell and later stage embryos, whereas COX-2 and PGIS became detectable in 4-cell and later stage embryos. Only the blastocysts are shown here; both the trophectoderm and the inner cell mass of blastocysts displayed immunostaining. All negative controls showed no staining (not shown). The bar is ~30 µm.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
We provide direct evidence, for the first time, for the synthesis of PGs by mouse blastocysts. We further demonstrate that mouse blastocysts synthesized abundant PGI2, which enhances complete hatching. The eicosanoid profile of blastocysts appears to be species specific. Our data reveal that mouse embryos produce, in order of abundance, PGI2, PGE2 and PGF2{alpha}. In this respect, mouse embryos are similar to sheep embryos which produce mainly PGI2 and PGF2{alpha}, but different from cattle and pig blastocysts which produce mostly PGF2{alpha} and PGE2, respectively (Lewis et al., 1989Go).

Our results confirmed earlier reports by Biggers et al. (1978)Go and Hurst and MacFarlane (1981)Go that indomethacin at a therapeutic concentration (~10 µmol/l) inhibited embryo hatching. The discrepancy between the aforementioned reports and the more recent reports by van der Weiden et al. (1993)Go and Chida et al. (1986)Go, which indicated that ~100 µmol/l indomethacin was required to inhibit embryo hatching, may be attributable to the protein in the medium. Rat serum (30 mg/ml) and BSA (5 mg/ml) were used in the studies by van der Weiden and Chida, respectively, whereas protein-free medium was used in earlier studies.

Our data are in agreement with those of previous reports that indomethacin at 10 µmol/l inhibited embryo hatching by ~40–50% (Biggers et al., 1978Go; Hurst and MacFarlane, 1981Go). Prior to this study, it was unclear how indomethacin inhibits embryo hatching. Results from this study indicate that the inhibitory action of indomethacin was attributable to its suppression of COX-2 activity, as the selective COX-2 inhibitor but not the COX-1 inhibitor reduced embryo hatching to an extent similar to indomethacin. Our results further show that COX-2-derived PGI2 may be the key AA metabolite required for embryo hatching. This notion is supported further by the analysis of AA metabolites: PGI2 was the predominant metabolite generated from radiolabelled AA by the embryos. Thus, indomethacin blocks PGI2 synthesis depriving the embryo of one of its key mediators required for its growth and hatching.

It is well known that PGI2 plays an important role in maintaining vascular homeostasis and controlling blood cell activity. That PGI2 has physiological functions outside the cardiovascular system was first suggested by observations made in COX-2-deficient mice (Lim et al., 1997Go), which underscores the indispensable role of endometrial COX-2-derived PGI2 in normal decidualization and receptivity. Subsequently, it has been reported that human (Huang et al., 2002Go) and mouse (Melham et al., 2004Go) oviducts produce PGI2 and that embryos exposed to PGI2 analogue between 8-cell and morula stages undergo enhanced hatching (Huang et al., 2003Go) and possess augmented potential for implantation and live birth (Huang et al., 2004Go). Collectively, PGI2 produced by the embryo and the oviduct acts as an autocrine/paracrine factor to enhance mouse embryo hatching, implantation and live birth.

It may be speculated that mice deficient in phopholipase A2, COX-2, PGIS or PGI2 receptor may produce smaller litters than their wild-type counterparts because their embryos, lacking the autocrine/paracrine effects of PGI2, may have decreased hatching and consequently lower implantation potential. Phospholipase A2-deficient mice have smaller litters than the wild-type (Bonventre et al., 1997Go). COX-2-deficient mice are sterile because they do not ovulate (Lim et al., 1997Go). The litter size of PGIS- (Yokoyama et al., 2002Go) and PGI2 receptor- (Murata et al., 1997Go) deficient mice has not been compared with that of the wild-types. However, it should be pointed out that breeding COX-2 heterozygous knockout mice (Morham et al., 1995Go) or PGI2 receptor heterozygous knockout mice (Murata et al., 1997Go) produced less homozygous offspring than expected based on Mendel's law. These observations suggest that PGI2 deficiency may compromise embryo hatching and decrease implantation potential.

Phenotypes of gene deficiency vary with the genetic backgrounds of the mice. For example, COX-2 deficiency causes sterility in C57BL/6J/129 mice (Lim et al., 1997Go) but subfertility in CD1 mice (Wang et al., 2004Go). The diverse genetic pool of CD1 mice does not completely reverse the adverse impacts of COX-2 deficiency. As a result, COX-2-deficient CD1 mice still display significant problems in ovulation and decidualization: they have significantly smaller litters and display significantly less receptivity to transferred wild-type embryos. These observations underscore the importance of COX-2 in ovulation and decidualization. However, the potentials of hatching and implantation of COX-2-deficient embryos were not reported.

Embryo-derived PGs may have other physiological functions such as regulating the transport of embryos. Results from HPLC analysis indicate that, in addition to PGI2, mouse embryos also produce PGE2 and PGF2{alpha}. Since oviducts express receptors for PGI2 (Arbab et al., 2002Go) and PGE2 (Segi et al., 2003Go), embryo-derived PGI2 and PGE2 may bind to these receptors, relax the muscle and regulate embryo transport.

The mechanisms by which PGI2 enhanced embryo hatching have not been elucidated. One possible mechanism is augmented ion/water transport across the tight junction between the inner cell mass and the trophectoderm (Biggers et al., 1988Go). Enhanced ion/water transport into blastocysts increases the blastocoel cavity and facilitates embryo hatching (Biggers et al., 1988Go). Alternatively, endogenous PGI2 may increase embryonic cell number by decreasing cell death or increasing cell proliferation. This is supported by a recent report which showed that compared with embryo hatching in vivo, embryos hatching in vitro require more embryonic cells (Montag et al., 2000Go). PGI2 has been shown to possess anti-apoptotic properties in renal glomerular mesangial cells (Ishaque et al., 2003Go) and colonic epithelial cells (Cutler et al., 2003Go). It is, therefore, possible that PGI2 enhances embryo hatching by promoting cell survival.

Although there is no direct evidence for the production of PG by human embryos, it is likely that human embryos, similar to their counterparts from sheep, cattle, rabbit and mouse, also produce PGs. Transcripts of phospholipase A2, COX-1 and COX-2 (Wang et al., 2002Go) and immunoreactive COX-2 protein (Wang et al., 2002Go) and PGE2 (Holmes et al., 1990Go) have been observed in human embryos. Embryo-derived PGs, together with oviduct-derived PGs (Huang et al., 2002Go), may augment the hatching of human embryos in a paracrine/autocrine fashion analogous to their augmentation of the hatching of mouse embryos. Therefore, the safety of non-steroidal anti-inflammatory drugs, especially the selective COX-2 inhibitors, in women desiring pregnancy may need to be re-evaluated.

Our immunohistochemistry study shows that the trophectoderm and the inner cell mass of mouse blastocysts express COX-1, COX-2 and PGIS. This is different from a previous report based on observations of triploid human embryos which show that trophectoderm, but not inner cell mass, expresses COX-2 (Wang et al., 2002Go). The discrepancy could be due to species differences or abnormal embryo development as a result of triploidy of chromosomes. Alternatively, it may be due to different methodologies used in the immunohistochemistry. We used Triton X-100 to permeate the tight junction between the trophectoderm and the inner cell mass prior to immunostaining, whereas no detergent was used in the above-mentioned study.

In summary, our results show that mouse embryos express COX-1, COX-2 and PGIS which catalyse the formation of PGI2, and that COX-2-derived PGI2 plays a critical role in embryo hatching.


    Acknowledgements
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
The work was supported in part by NIH grants to K.K.W. (NS-23327 and H.L.-50675) J.-C.H. is a WRHR scholar (HD 01277).


    References
 Top
 Abstract
 Introduction
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Arbab F, Goldsby J, Matijevic-Aleksic N, Huang G, Ruan KH and Huang JC (2002) Prostacyclin is an autocrine regulator in the contraction of oviductal smooth muscle. Hum Reprod 17, 3053–3059.[Abstract/Free Full Text]

Biggers JD, Leonov BV, Baskar JF and Fried J (1978) Inhibition of hatching of mouse blastocysts in vitro by prostaglandin antagonists. Biol Reprod 19, 519–533.[ISI][Medline]

Biggers JD, Bell JE and Benos DJ (1988) Mammalian blastocyst: transport functions in a developing epithelium. Am J Physiol 255, C419–C432.[ISI][Medline]

Bonventre JV, Huang Z, Taheri MR, O'Leary E, Li E, Moskowitz MA and Sapirstein A (1997) Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature 390, 622–625.[CrossRef][ISI][Medline]

Brison DR and Schultz RM (1997) Apoptosis during mouse blastocyst formation: evidence for a role for survival factors including transforming growth factor alpha. Biol Reprod 56, 1088–1096.[Abstract]

Chida S, Uehara S, Hoshiai H and Yajima A (1986) Effects of indomethacin, prostaglandin E2, prostaglandin F2 alpha and 6-keto-prostaglandin F1 alpha on hatching of mouse blastocysts. Prostaglandins 31, 337–342.[CrossRef][Medline]

Cutler NS, Graves-Deal R, LaFleur BJ, Gao Z, Boman BM, Whitehead RH, Terry E, Morrow JD and Coffey RJ (2003) Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells. Cancer Res 63, 1748–1751.[Abstract/Free Full Text]

Hartshorne GM and Edwards RG (1991) Role of embryonic factors in implantation: recent developments. Baillieres Clin Obstet Gynaecol 5, 133–158.[ISI][Medline]

Holmes PV, Sjogren A and Hamberger L (1990) Prostaglandin-E2 released by pre-implantation human conceptuses. J Reprod Immunol 17, 79–86.[CrossRef][ISI][Medline]

Huang J-C, Arbab F, Tumbusch KJ, Goldsby JS, Matijevic-Aleksic N and Wu KK (2002) Human Fallopian tubes express prostacyclin (PGI) synthase and cyclooxygenases and synthesize abundant PGI. J Clin Endocrinol Metab 87, 4361–4368.[Abstract/Free Full Text]

Huang J-C, Wun W-SA, Goldsby JS, Wun IC, Falconi SM and Wu KK (2003) Prostacyclin enhances embryo hatching but not sperm motility. Hum Reprod 18, 2582–2589.[Abstract/Free Full Text]

Huang J-C, Goldsby J and Wun W-SA (2004) Prostacyclin enhances the potentials of implantation and live birth of mouse embryos. Hum Reprod 19, 1856–1860.[Abstract/Free Full Text]

Hurst PR and MacFarlane DW (1981) Further effects of nonsteroidal anti-inflammatory compounds on blastocyst hatching in vitro and implantation rates in the mouse. Biol Reprod 25, 777–784.[ISI][Medline]

Ishaque A, Dunn MJ and Sorokin A (2003) Cyclooxygenase-2 inhibits tumor necrosis factor alpha-mediated apoptosis in renal glomerular mesangial cells. J Biol Chem 278, 10629–10640.[Abstract/Free Full Text]

Lewis GS, Chida S, Uehara S, Hoshiai H and Yajima A (1989) Prostaglandin secretion by the blastocyst. Effects of indomethacin, prostaglandin E2, prostaglandin F2 alpha and 6-keto-prostaglandin F1 alpha on hatching of mouse blastocysts. J Reprod Fertil Suppl 37, 261–267.[Medline]

Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM and Dey SK (1997) Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell 91, 197–208.[ISI][Medline]

Lim H, Gupta RA, Ma WG, Paria BC, Moller DE, Morrow JD, DuBois RN, Trzaskos JM and Dey SK (1999) Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta. Genes Dev 13, 1561–1574.[Abstract/Free Full Text]

Lu DP, Chandrakanthan V, Cahana A, Ishii S and O'Neill C (2004) Trophic signals acting via phosphatidylinositol-3 kinase are required for normal pre-implantation mouse embryo development. J Cell Sci 117, 1567–1576.[Abstract/Free Full Text]

Melham Z, Goldsby JS, Arbab F, Alecsic N and Huang JC (2004) Oviduct prostacyclin enhances pre-implantation embryo hatching in a paracrine fashion. J Soc Gynecol Invest 11, 288A.

Montag M, Koll B, Holmes P and van der Ven H (2000) Significance of the number of embryonic cells and the state of the zona pellucida for hatching of mouse blastocysts in vitro versus in vivo. Biol Reprod 62, 1738–1744.[Abstract/Free Full Text]

Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA et al. (1995) Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83, 473–482.[ISI][Medline]

Murata T, Ushikubi F, Matsuoka T, Hirata M, Yamasaki A, Sugimoto Y, Ichikawa A, Aze Y, Tanaka T, Yoshida N, Ueno A, Oh-ishi S and Narumiya S (1997) Altered pain perception and inflammatory response in mice lacking prostacyclin receptor. Nature 388, 678–682.[CrossRef][ISI][Medline]

Niimura S and Ishida K (1987) Immunohistochemical demonstration of prostaglandin E-2 in preimplantation mouse embryos. J Reprod Fertil 80, 505–508.[ISI][Medline]

Sanduja SK, Mehta K, Xu XM, Hsu SM, Sanduja R and Wu KK (1991) Differentiation-associated expression of prostaglandin H and thromboxane A synthases in monocytoid leukemia cell lines. Blood 78, 3178–3185.[Abstract]

Segi E, Haraguchi K, Sugimoto Y, Tsuji M, Tsunekawa H, Tamba S, Tsuboi K, Tanaka S and Ichikawa A (2003) Expression of messenger RNA for prostaglandin E receptor subtypes EP4/EP2 and cyclooxygenase isozymes in mouse periovulatory follicles and oviducts during superovulation. Biol Reprod 68, 804–811.[Abstract/Free Full Text]

Takami T, Sakamoto H, Takami M, Hayakawa S and Satoh K (1994) [Cyclooxygenase in ooplasm is essential for early embryonal differentiation but not for successful fertilization in the mouse]. Nippon Sanka Fujinka Gakkai Zasshi 46, 295–300.[Medline]

van der Weiden RM, Verdijk RM, Poelmann RE, Helmerhorst FM and Keirse MJ (1993) The influence of indomethacin on the hatching of mouse blastocysts. Prostaglandins Leukot Essent Fatty Acids 49, 683–686.[CrossRef][ISI][Medline]

van der Weiden RM, Wisse LJ, Helmerhorst FM, Keirse MJ and Poelmann RE (1996) Immunohistochemical and ultrastructural localization of prostaglandin H synthase in the preimplantation mouse embryo. J Reprod Fertil 107, 161–166.[ISI][Medline]

Wang H, Wen Y, Mooney S, Behr B and Polan ML (2002) Phospholipase A(2) and cyclooxygenase gene expression in human preimplantation embryos. J Clin Endocrinol Metab 87, 2629–2634.[Abstract/Free Full Text]

Wang H, Ma W-G, Tejada L, Zhang H, Morrow JD, Das SK and Dey SK (2004) Rescue of female infertility from the loss of cyclooxygenase-2 by compensatory up-regulation of cyclooxygenase-1 is a function of genetic makeup. J Biol Chem 279, 10649–10658.[Abstract/Free Full Text]

Yokoyama C, Yabuki T, Shimonishi M, Wada M, Hatae T, Ohkawara S, Takeda J, Kinoshita T, Okabe M and Tanabe T (2002) Prostacyclin-deficient mice develop ischemic renal disorders, including nephrosclerosis and renal infarction. Circulation 106, 2397–2403.[Abstract/Free Full Text]

Submitted on May 26, 2004; accepted on August 19, 2004.